180 related articles for article (PubMed ID: 30366205)
1. Distinct roles for Blimp-1 in autoreactive CD4 T cells during priming and effector phase of autoimmune encephalomyelitis.
Aqel SI; Granitto MC; Nuro-Gyina PK; Pei W; Liu Y; Lovett-Racke AE; Racke MK; Yang Y
J Neuroimmunol; 2018 Dec; 325():20-28. PubMed ID: 30366205
[TBL] [Abstract][Full Text] [Related]
2. T cell-specific BLIMP-1 deficiency exacerbates experimental autoimmune encephalomyelitis in nonobese diabetic mice by increasing Th1 and Th17 cells.
Lin MH; Yeh LT; Chen SJ; Chiou HY; Chu CC; Yen LB; Lin KI; Chang DM; Sytwu HK
Clin Immunol; 2014 Apr; 151(2):101-13. PubMed ID: 24568746
[TBL] [Abstract][Full Text] [Related]
3. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
4. Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα.
Nuro-Gyina PK; Rieser EL; Granitto MC; Pei W; Liu Y; Lee PW; Aqel S; Zhang J; Lovett-Racke AE; Racke MK; Yang Y
J Neuroinflammation; 2016 Dec; 13(1):302. PubMed ID: 27912762
[TBL] [Abstract][Full Text] [Related]
5. Regulation of autoreactive CD4 T cells by FoxO1 signaling in CNS autoimmunity.
Kraus EE; Kakuk-Atkins L; Farinas MF; Jeffers M; Lovett-Racke AE; Yang Y
J Neuroimmunol; 2021 Oct; 359():577675. PubMed ID: 34403862
[TBL] [Abstract][Full Text] [Related]
6. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
7. CCR7 on CD4
Belikan P; Bühler U; Wolf C; Pramanik GK; Gollan R; Zipp F; Siffrin V
J Immunol; 2018 Apr; 200(8):2554-2562. PubMed ID: 29549177
[TBL] [Abstract][Full Text] [Related]
8. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
9. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
[TBL] [Abstract][Full Text] [Related]
10. Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitis.
Yeh WI; McWilliams IL; Harrington LE
J Immunol; 2011 Nov; 187(10):4998-5006. PubMed ID: 21984703
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
[TBL] [Abstract][Full Text] [Related]
12. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 gain-of-function in CD4
Braga TT; Brandao WN; Azevedo H; Terra FF; Melo ACL; Pereira FV; Andrade-Oliveira V; Hiyane MI; Peron JPS; Camara NOS
Clin Sci (Lond); 2019 Sep; 133(17):1901-1916. PubMed ID: 31471462
[TBL] [Abstract][Full Text] [Related]
14. B lymphocyte-induced maturation protein-1 contributes to intestinal mucosa homeostasis by limiting the number of IL-17-producing CD4+ T cells.
Salehi S; Bankoti R; Benevides L; Willen J; Couse M; Silva JS; Dhall D; Meffre E; Targan S; Martins GA
J Immunol; 2012 Dec; 189(12):5682-93. PubMed ID: 23162130
[TBL] [Abstract][Full Text] [Related]
15. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
16. Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.
Yang H; Qiu Q; Gao B; Kong S; Lin Z; Fang D
J Exp Med; 2014 Nov; 211(12):2467-79. PubMed ID: 25366967
[TBL] [Abstract][Full Text] [Related]
17. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
18. Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice.
Ghosh D; Curtis AD; Wilkinson DS; Mannie MD
J Leukoc Biol; 2016 Oct; 100(4):747-760. PubMed ID: 27256565
[TBL] [Abstract][Full Text] [Related]
19. B lymphocyte-induced maturation protein 1 (BLIMP-1) attenuates autoimmune diabetes in NOD mice by suppressing Th1 and Th17 cells.
Lin MH; Chou FC; Yeh LT; Fu SH; Chiou HY; Lin KI; Chang DM; Sytwu HK
Diabetologia; 2013 Jan; 56(1):136-46. PubMed ID: 23052053
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV regulates differentiation and induces apoptosis of activated CD4
Yang L; Xing F; Han X; Li Q; Wu H; Shi H; Wang Z; Huang F; Wu X
Toxicol Appl Pharmacol; 2019 Jan; 362():105-115. PubMed ID: 30385269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
